Blood Cancer Talks Episode 30. Management of High-Risk Myeloma
Sep 13, 2023
The podcast discusses the management of high-risk myeloma, including genetic markers and prognostic factors. It explores the impact of Dell 1P32 and other chromosome 1 nuances on newly diagnosed myeloma. Treatment options and the role of autologous transplant are also discussed. Implementation of gene expression profiling and genetic profiling in managing high-risk myeloma is highlighted. The challenges of using synthetic control arms in clinical trials and the management of high-risk myeloma are explored.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 5min
High-Risk Multiple Myeloma: Genetic Markers and Prognostic Factors
04:32 • 23min
Understanding the Impact of Dell 1P32 and Other Chromosome 1 Nuances on Newly Diagnosed Melanoma
27:19 • 3min
Treatment options for high-risk myeloma and the role of autologous transplant
30:40 • 16min
Implementation of Gene Expression Profiling and Genetic Profiling in Managing High-Risk Myeloma
46:47 • 7min
Considerations and Challenges of Using Synthetic Control Arms
53:58 • 9min
Management of High-Risk Myeloma and Health Technology Assessment
01:03:07 • 5min